Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Ribi, ATL collaborate on the development of improved allergy vaccines

Oct. 20, 1998

Certiva vaccine launched in the U.S.

Oct. 16, 1998

Orphan drug designation granted to MEDI-507 for use in AlloMune system

Oct. 16, 1998

Data safety monitoring board deems Nabi S. aureus vaccine safe in hemodialysis patients

Oct. 16, 1998

Aquila reports preliminary results of phase II trial of pneumococcal vaccine

Oct. 16, 1998

New compound reported in clinical development at Lilly

Oct. 15, 1998

Immunomodulating thalidomide analogues patented by Gruenenthal

Oct. 14, 1998

Ono's new PGE2 derivatives show binding affinity for EP2 receptors

Oct. 13, 1998

Development status updated for 3M's imiquimod analogue R-848

Oct. 7, 1998

La Jolla enrolls patients in phase II/III trial for lupus treatment

Oct. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...